Sonavex Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Series A2

  • Latest Deal Amount
  • $11M

  • Investors
  • 30

Sonavex General Information

Description

Developer of a bioresorbable and echogenic equipment technology designed to mark at-risk blood vessels such that the site can be easily assessed for future complications. The company's technology collects arteriovenous fistula volumetric flow rate, diameter, and depth information at the dialysis clinic to support maturation assessment, enabling healthcare providers to assess blood flow and morphology of vessels and get actionable data to deliver patient care.

Contact Information

Website
www.sonavex.com
Formerly Known As
Veridian Surgical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Therapeutic Devices
Other Healthcare Technology Systems
Corporate Office
  • 2835 O'Donnell Street
  • Suite 200
  • Baltimore, MD 21224
  • United States
+1 (443) 000-0000

Sonavex Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sonavex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
19. Later Stage VC (Series A2) 16-Apr-2024 $11M 000.00 0000 Completed Generating Revenue
18. Secondary Transaction - Private 000.00 Completed Generating Revenue
17. Later Stage VC (Series A2) 26-Jan-2023 000 000.00 0000 Completed Generating Revenue
16. Grant 30-Jun-2022 00000 00.00 Completed Generating Revenue
15. Grant 25-May-2022 00.00 00.00 Completed Generating Revenue
14. Grant 15-Sep-2021 00.00 00.00 Completed Generating Revenue
13. Accelerator/Incubator 01-Jun-2020 00.00 Completed Generating Revenue
12. Debt - PPP 15-Apr-2020 00000 00.00 Completed Generating Revenue
11. Later Stage VC (Series A1) 31-Jan-2020 $4.3M $9.1M 0000 Completed Clinical Trials - Phase 1
10. Grant 29-Aug-2019 $3M $4.82M Completed Clinical Trials - Phase 1
To view Sonavex’s complete valuation and funding history, request access »

Sonavex Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2 0,000,000 00.000000 000.00 000.00 00 000.00 00.000
Series A-1 000,000 00.000000 000.00 000.00 00 000.00 00.00
Series A 674,237 $0.000100 $7.04 $7.04 1x $7.04 20.09%
Seed 140,464 $0.000100 $2.37 $2.37 1x $2.37 4.19%
To view Sonavex’s complete cap table history, request access »

Sonavex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a bioresorbable and echogenic equipment technology designed to mark at-risk blood vessels such that the sit
Monitoring Equipment
Baltimore, MD
19 As of 2024
000.00
0000 0000-00-00
00000000000 000.00

0000

ehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Except
00000 0000000000 000
Broomfield, CO
00 As of 0000
000.00
00000 0000-00-00
00000000000 000.00

000000

ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000000000 000000000
Redmond, WA
000 As of 0000
00000
0000000 0000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sonavex Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alio Venture Capital-Backed Broomfield, CO 00 000.00 00000000000 000.00
EchoNous Private Equity-Backed Redmond, WA 000 00000 0000000 0000 00000
FUJIFILM SonoSite Corporate Backed or Acquired Bothell, WA 000 000000&0
Adorable Baby 3d 4d Ultrasound Studio Danville, Ca Corporation Danville, CA
To view Sonavex’s complete competitors history, request access »

Sonavex Patents

Sonavex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2016293866-A1 Microcavity-containing polymeric medical devices for enhanced ultrasonic echogenicity Inactive 16-Jul-2015 000000000
US-20170014102-A1 Microcavity-containing polymeric medical devices for enhanced ultrasonic echogenicity Inactive 16-Jul-2015 000000000 0
EP-3322345-A1 Microcavity-containing polymeric medical devices for enhanced ultrasonic echogenicity Pending 16-Jul-2015 000000000
US-20200139592-A1 Microcavity-containing polymeric medical devices for enhanced ultrasonic echogenicity Inactive 16-Jul-2015 000000000
JP-2018522698-A Polymer medical devices containing microcavities for enhancing ultrasound echo brightness Pending 16-Jul-2015 B29C44/02 00
To view Sonavex’s complete patent history, request access »

Sonavex Executive Team (7)

Name Title Board Seat Contact Info
David Narrow Co-Founder, Chief Executive Officer & Board Member
John Rappe Chief Business Officer
Devin O'Brien-Coon MD Co-Founder & Chairman
Jerry Prince Ph.D Co-Founder & Board Member
Xin Kang Ph.D Vice President of Research & Development
You’re viewing 5 of 7 executive team members. Get the full list »

Sonavex Board Members (5)

Name Representing Role Since
David Narrow Sonavex Co-Founder, Chief Executive Officer & Board Member 000 0000
Devin O'Brien-Coon MD Sonavex Co-Founder & Chairman 000 0000
Jerry Prince Ph.D Sonavex Co-Founder & Board Member 000 0000
Robert Hallenbeck Sonavex Board Member 000 0000
William Niland Self Board Member 000 0000
To view Sonavex’s complete board members history, request access »

Sonavex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sonavex Investors (30)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Riptide Ventures Angel Group Minority 000 0000 000000 0
Unorthodox Ventures Venture Capital Minority 000 0000 000000 0
Treedom House Family Office Minority 000 0000 000000 0
National Institute of Diabetes and Digestive and Kidney Diseases Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
You’re viewing 5 of 30 investors. Get the full list »

Sonavex FAQs

  • When was Sonavex founded?

    Sonavex was founded in 2013.

  • Who is the founder of Sonavex?

    David Narrow, Devin O'Brien-Coon MD, and Jerry Prince Ph.D are the founders of Sonavex.

  • Who is the CEO of Sonavex?

    David Narrow is the CEO of Sonavex.

  • Where is Sonavex headquartered?

    Sonavex is headquartered in Baltimore, MD.

  • What is the size of Sonavex?

    Sonavex has 19 total employees.

  • What industry is Sonavex in?

    Sonavex’s primary industry is Monitoring Equipment.

  • Is Sonavex a private or public company?

    Sonavex is a Private company.

  • What is the current valuation of Sonavex?

    The current valuation of Sonavex is 0000.

  • What is Sonavex’s current revenue?

    The current revenue for Sonavex is 00000.

  • How much funding has Sonavex raised over time?

    Sonavex has raised $24.1M.

  • Who are Sonavex’s investors?

    Riptide Ventures, Unorthodox Ventures, Treedom House, National Institute of Diabetes and Digestive and Kidney Diseases, and National Institutes of Health are 5 of 30 investors who have invested in Sonavex.

  • Who are Sonavex’s competitors?

    Alio, EchoNous, FUJIFILM SonoSite, and Adorable Baby 3d 4d Ultrasound Studio Danville, Ca are competitors of Sonavex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »